{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:01:33Z","timestamp":1792155693569,"version":"4.4.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000308","name":"Carnegie Corporation of New York","doi-asserted-by":"publisher","award":["B 8606.R02"],"award-info":[{"award-number":["B 8606.R02"]}],"id":[{"id":"10.13039\/100000308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004441","name":"Sida","doi-asserted-by":"crossref","award":["54100113"],"award-info":[{"award-number":["54100113"]}],"id":[{"id":"10.13039\/100004441","id-type":"DOI","asserted-by":"crossref"}]},{"name":"DELTAS Africa Initiative","award":["107768\/Z\/15\/Z"],"award-info":[{"award-number":["107768\/Z\/15\/Z"]}]},{"name":"Deutscher Akademischer Austauschdienst"},{"name":"Tropical Diseases Modelling (TDMOD) network"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"name":"HDR UK Innovation Fellowship","award":["MR\/S003975\/1"],"award-info":[{"award-number":["MR\/S003975\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>There is substantial burden of seasonal influenza in Kenya, which led the government to consider introducing a national influenza vaccination programme. Given the cost implications of a nationwide programme, local economic evaluation data are needed to inform policy on the design and benefits of influenza vaccination. We set out to estimate the cost-effectiveness of seasonal influenza vaccination in Kenya.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We fitted an age-stratified dynamic transmission model to active surveillance data from patients with influenza from 2010 to 2018. Using a societal perspective, we developed a decision tree cost-effectiveness model and estimated the incremental cost-effectiveness ratio (ICER) per disability-adjusted life year (DALY) averted for three vaccine target groups: children 6\u201323\u2009months (strategy I), 2\u20135\u2009years (strategy II) and 6\u201314\u2009years (strategy III) with either the Southern Hemisphere influenza vaccine (Strategy A) or Northern Hemisphere vaccine (Strategy B) or both (Strategy C: twice yearly vaccination campaigns, or Strategy D: year-round vaccination campaigns). We assessed cost-effectiveness by calculating incremental net monetary benefits (INMB) using a willingness-to-pay (WTP) threshold of 1\u201351% of the annual gross domestic product per capita ($17\u2013$872).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The mean number of infections across all ages was 2\u201315 million per year. When vaccination was well timed to influenza activity, the annual mean ICER per DALY averted for vaccinating children 6\u201323\u2009months ranged between $749 and $1385 for strategy IA, $442 and $1877 for strategy IB, $678 and $4106 for strategy IC and $1147 and $7933 for strategy ID. For children 2\u20135\u2009years, it ranged between $945 and $1573 for strategy IIA, $563 and $1869 for strategy IIB, $662 and $4085 for strategy IIC, and $1169 and $7897 for strategy IID. For children 6\u201314\u2009years, it ranged between $923 and $3116 for strategy IIIA, $1005 and $2223 for strategy IIIB, $883 and $4727 for strategy IIIC and $1467 and $6813 for strategy IIID. Overall, no vaccination strategy was cost-effective at the minimum ($17) and median ($445) WTP thresholds. Vaccinating children 6\u201323\u2009months once a year had the highest mean INMB value at $872 (WTP threshold upper limit); however, this strategy had very low probability of the highest net benefit.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Vaccinating children 6\u201323\u2009months once a year was the most favourable vaccination option; however, the strategy is unlikely to be cost-effective given the current WTP thresholds.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12916-020-01687-7","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T01:02:40Z","timestamp":1597885360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9405-148X","authenticated-orcid":false,"given":"Jeanette","family":"Dawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon O.","family":"Emukule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwine","family":"Barasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Alain","family":"Widdowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omu","family":"Anzala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Baguelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra S.","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind M.","family":"Eggo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"issue":"1","key":"1687_CR1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/irv.12488","volume":"12","author":"JA Dawa","year":"2018","unstructured":"Dawa JA, Chaves SS, Nyawanda B, Njuguna HN, Makokha C, Otieno NA, et al. National burden of hospitalized and non-hospitalized influenza-associated severe acute respiratory illness in Kenya, 2012-2014. Influenza Other Respir Viruses. 2018;12(1):30\u20137.","journal-title":"Influenza Other Respir Viruses"},{"key":"1687_CR2","doi-asserted-by":"crossref","unstructured":"Emukule GO, Paget J, van der Velden K, Mott JA. Influenza-Associated Disease Burden in Kenya: A Systematic Review of Literature. PLoS One. 2015;10(9):1\u201314.","DOI":"10.1371\/journal.pone.0138708"},{"key":"1687_CR3","volume-title":"Communication to stakeholders: Progress update on plans to introduce influenza vaccine into routine immunization in Kenya","author":"Office of Director of Medical Services Ministry of Health","year":"2016","unstructured":"Office of Director of Medical Services Ministry of Health. Communication to stakeholders: Progress update on plans to introduce influenza vaccine into routine immunization in Kenya. Nairobi: Ministry of Health, Kenya; 2016."},{"issue":"3","key":"1687_CR4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.vaccine.2018.11.062","volume":"37","author":"J Dawa","year":"2019","unstructured":"Dawa J, Chaves SS, Ba Nguz A, Kalani R, Anyango E, Mutie D, et al. Developing a seasonal influenza vaccine recommendation in Kenya: process and challenges faced by the National Immunization Technical Advisory Group (NITAG). Vaccine. 2019;37(3):464\u201372.","journal-title":"Vaccine."},{"issue":"7","key":"1687_CR5","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.4161\/hv.24704","volume":"9","author":"JJ Ott","year":"2013","unstructured":"Ott JJ, Klein Breteler J, Tam JS, Hutubessy RC, Jit M, de Boer MR. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations. Hum Vaccines Immunotherapeutics. 2013;9(7):1500\u201311.","journal-title":"Hum Vaccines Immunotherapeutics."},{"issue":"3","key":"1687_CR6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4161\/hv.23269","volume":"9","author":"L Salleras","year":"2013","unstructured":"Salleras L, Navas E, Torner N, Prat AA, Garrido P, Soldevila N, et al. Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children. Hum Vaccines Immunotherapeutics. 2013;9(3):707\u201311.","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"1687_CR7","volume-title":"Which vaccine formulation to use \u2013 Northern or Southern Hemisphere?","author":"World Health Organisation","year":"2017","unstructured":"World Health Organisation. Which vaccine formulation to use \u2013 Northern or Southern Hemisphere? 2017. Available from: https:\/\/www.who.int\/influenza\/vaccines\/tropics\/vaccination_formulation\/en\/.[updated 12 September 2017; cited 2019 June 22]."},{"key":"1687_CR8","volume-title":"Vaccination timing","author":"World Health Organisation","year":"2017","unstructured":"World Health Organisation. Vaccination timing 2017. Available from: https:\/\/www.who.int\/influenza\/vaccines\/tropics\/vaccination_timing\/en\/. [updated 12 September 2017; cited 2019 June 22]."},{"issue":"6","key":"1687_CR9","doi-asserted-by":"crossref","first-page":"e98615","DOI":"10.1371\/journal.pone.0098615","volume":"9","author":"MA Katz","year":"2014","unstructured":"Katz MA, Muthoka P, Emukule GO, Kalani R, Njuguna H, Waiboci LW, et al. Results from the first six years of national sentinel surveillance for influenza in Kenya, July 2007-June 2013. PLoS One. 2014;9(6):e98615.","journal-title":"PLoS One"},{"issue":"23","key":"1687_CR10","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.vaccine.2016.03.095","volume":"34","author":"LW Waiboci","year":"2016","unstructured":"Waiboci LW, Mott JA, Kikwai G, Arunga G, Xu X, Mayieka L, et al. Which influenza vaccine formulation should be used in Kenya? A comparison of influenza isolates from Kenya to vaccine strains, 2007-2013. Vaccine. 2016;34(23):2593\u2013601.","journal-title":"Vaccine."},{"key":"1687_CR11","doi-asserted-by":"crossref","unstructured":"Yue M, Dickens BL, Yoong JS-Y, I-Cheng Chen M, Teerawattananon Y, Cook AR. Cost-effectiveness analysis for influenza vaccination coverage and timing in tropical and subtropical climate settings: a modeling study. Value in Health. 2019:22(12):1345\u201354.","DOI":"10.1016\/j.jval.2019.07.001"},{"key":"1687_CR12","doi-asserted-by":"crossref","unstructured":"Mertz D, Fadel SA, Lam PP, Tran D, Srigley JA, Asner SA, et al. Herd effect from influenza vaccination in non-healthcare settings: a systematic review of randomised controlled trials and observational studies. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2016;21(42):1\u20139.","DOI":"10.2807\/1560-7917.ES.2016.21.42.30378"},{"issue":"1","key":"1687_CR13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12879-017-2399-4","volume":"17","author":"M Eichner","year":"2017","unstructured":"Eichner M, Schwehm M, Eichner L, Gerlier L. Direct and indirect effects of influenza vaccination. BMC Infect Dis. 2017;17(1):308.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"1687_CR14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jval.2012.06.011","volume":"15","author":"R Pitman","year":"2012","unstructured":"Pitman R, Fisman D, Zaric GS, Postma M, Kretzschmar M, Edmunds J, et al. Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5. Value Health. 2012;15(6):828\u201334.","journal-title":"Value Health"},{"issue":"23","key":"1687_CR15","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.vaccine.2012.03.019","volume":"30","author":"M Baguelin","year":"2012","unstructured":"Baguelin M, Jit M, Miller E, Edmunds WJ. Health and economic impact of the seasonal influenza vaccination programme in England. Vaccine. 2012;30(23):3459\u201362.","journal-title":"Vaccine."},{"key":"1687_CR16","doi-asserted-by":"crossref","unstructured":"Baguelin M, Flasche S, Camacho A, Demiris N, Miller E, Edmunds WJ. Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study. PLoS Med. 2013;10.","DOI":"10.1371\/journal.pmed.1001527"},{"key":"1687_CR17","volume-title":"Kenya Master Health Facility List: Government of Kenya","author":"Ministy of Health","year":"2020","unstructured":"Ministy of Health. Kenya Master Health Facility List: Government of Kenya; 2020. Available from: http:\/\/kmhfl.health.go.ke\/#\/gis. [cited 2020 3 March]."},{"issue":"8","key":"1687_CR18","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/infdis\/jit316","volume":"208","author":"SS Chaves","year":"2013","unstructured":"Chaves SS, Aragon D, Bennett N, Cooper T, D'Mello T, Farley M, et al. Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype. J Infect Dis. 2013;208(8):1305\u201314.","journal-title":"J Infect Dis"},{"issue":"10","key":"1687_CR19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1365-3156.2003.01112.x","volume":"8","author":"AM Noor","year":"2003","unstructured":"Noor AM, Zurovac D, Hay SI, Ochola SA, Snow RW. Defining equity in physical access to clinical services using geographical information systems as part of malaria planning and monitoring in Kenya. Trop Med Int Health. 2003;8(10):917\u201326.","journal-title":"Trop Med Int Health"},{"issue":"5","key":"1687_CR20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/irv.12393","volume":"10","author":"GO Emukule","year":"2016","unstructured":"Emukule GO, Mott JA, Spreeuwenberg P, Viboud C, Commanday A, Muthoka P, et al. Influenza activity in Kenya, 2007-2013: timing, association with climatic factors, and implications for vaccination campaigns. Influenza Other Respir Viruses. 2016;10(5):375\u201385.","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"1687_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-015-0452-y","volume":"13","author":"M Baguelin","year":"2015","unstructured":"Baguelin M, Camacho A, Flasche S, Edmunds WJ. Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study. BMC Med. 2015;13(1):1\u201313.","journal-title":"BMC Med"},{"issue":"8","key":"1687_CR22","doi-asserted-by":"crossref","first-page":"e104786","DOI":"10.1371\/journal.pone.0104786","volume":"9","author":"MC Kiti","year":"2014","unstructured":"Kiti MC, Kinyanjui TM, Koech DC, Munywoki PK, Medley GF, Nokes DJ. Quantifying age-related rates of social contact using diaries in a rural coastal population of Kenya. PLoS One. 2014;9(8):e104786.","journal-title":"PLoS One"},{"issue":"11","key":"1687_CR23","doi-asserted-by":"crossref","first-page":"e1005838","DOI":"10.1371\/journal.pcbi.1005838","volume":"13","author":"E van Leeuwen","year":"2017","unstructured":"van Leeuwen E, Klepac P, Thorrington D, Pebody R, Baguelin M. fluEvidenceSynthesis: An R package for evidence synthesis based analysis of epidemiological outbreaks. PLOS Comput Biol. 2017;13(11):e1005838.","journal-title":"PLOS Comput Biol"},{"key":"1687_CR24","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2016","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2016."},{"key":"1687_CR25","doi-asserted-by":"crossref","unstructured":"Katz MA, Lebo E, Emukule GO, Otieno N, Caselton DL, Bigogo G, et al. Uptake and effectiveness of a trivalent inactivated influenza vaccine in children in urban and rural Kenya, 2010-2012. Pediatr Infect Dis J 2015:35(3):322\u20139.","DOI":"10.1097\/INF.0000000000001035"},{"key":"1687_CR26","volume-title":"Correlates of vaccine-induced protection: methods and implications","author":"World Health Organisation","year":"2013","unstructured":"World Health Organisation. Correlates of vaccine-induced protection: methods and implications. Geneva: World Health Organisation; 2013."},{"key":"1687_CR27","doi-asserted-by":"crossref","unstructured":"Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167:775\u201385.","DOI":"10.1093\/aje\/kwm375"},{"key":"1687_CR28","unstructured":"Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2016 (GBD 2016) Disability Weights 2019 [cited 2019 June 9]. Available from: http:\/\/ghdx.healthdata.org\/record\/ihme-data\/gbd-2016-disability-weights."},{"issue":"7","key":"1687_CR29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.vaccine.2017.12.073","volume":"36","author":"PT de Boer","year":"2018","unstructured":"de Boer PT, Kelso JK, Halder N, Nguyen T-P-L, Moyes J, Cohen C, et al. The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia. Vaccine. 2018;36(7):997\u20131007.","journal-title":"Vaccine"},{"issue":"3","key":"1687_CR30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12889-019-6773-6","volume":"19","author":"GO Emukule","year":"2019","unstructured":"Emukule GO, Ndegwa LK, Washington ML, Paget JW, Duque J, Chaves SS, et al. The cost of influenza-associated hospitalizations and outpatient visits in Kenya. BMC Public Health. 2019;19(3):471.","journal-title":"BMC Public Health"},{"issue":"23","key":"1687_CR31","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.vaccine.2015.03.084","volume":"33","author":"M Mvundura","year":"2015","unstructured":"Mvundura M, Lorenson K, Chweya A, Kigadye R, Bartholomew K, Makame M, et al. Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania. Vaccine. 2015;33(23):2697\u2013703.","journal-title":"Vaccine."},{"key":"1687_CR32","volume-title":"Monitoring vaccine wastage at country level. Guidelines for programme managers","author":"World Health Organisation","year":"2005","unstructured":"World Health Organisation. Monitoring vaccine wastage at country level. Guidelines for programme managers. Geneva: World Health Organisation; 2005."},{"issue":"3","key":"1687_CR33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00038-014-0552-z","volume":"59","author":"B Devleesschauwer","year":"2014","unstructured":"Devleesschauwer B, Havelaar AH, Maertens de Noordhout C, Haagsma JA, Praet N, Dorny P, et al. Calculating disability-adjusted life years to quantify burden of disease. Int J Public Health. 2014;59(3):565\u20139.","journal-title":"Int J Public Health"},{"issue":"8","key":"1687_CR34","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jval.2016.02.017","volume":"19","author":"B Woods","year":"2016","unstructured":"Woods B, Revill P, Sculpher M, Claxton K. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health. 2016;19(8):929\u201335.","journal-title":"Value Health"},{"key":"1687_CR35","volume-title":"WHO guide for standardization of economic evaluations of immunization programmes","author":"World Health Organisation","year":"2019","unstructured":"World Health Organisation. WHO guide for standardization of economic evaluations of immunization programmes. 2nd ed. Geneva: World Health Organisation; 2019.","edition":"2"},{"issue":"13","key":"1687_CR36","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.vaccine.2004.09.025","volume":"23","author":"PA Piedra","year":"2005","unstructured":"Piedra PA, Gaglani MJ, Kozinetz CA, Herschler G, Riggs M, Griffith M, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine. 2005;23(13):1540\u20138.","journal-title":"Vaccine."},{"issue":"4","key":"1687_CR37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcv.2006.08.020","volume":"37","author":"WP Glezen","year":"2006","unstructured":"Glezen WP. Herd protection against influenza. J Clin Virol. 2006;37(4):237\u201343.","journal-title":"J Clin Virol"},{"issue":"44","key":"1687_CR38","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1016\/j.vaccine.2019.08.069","volume":"37","author":"V Costantino","year":"2019","unstructured":"Costantino V, Trent M, MacIntyre CR. Modelling of optimal timing for influenza vaccination as a function of intraseasonal waning of immunity and vaccine coverage. Vaccine. 2019;37(44):6768\u201375.","journal-title":"Vaccine."},{"key":"1687_CR39","doi-asserted-by":"crossref","unstructured":"Ferdinands JM, Alyanak E, Reed C, Fry AM. Waning of influenza vaccine protection: exploring the trade-offs of changes in vaccination timing among older adults. Clin Infect Dis. 2019;70(8):1550\u20139.","DOI":"10.1093\/cid\/ciz452"},{"issue":"39","key":"1687_CR40","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1016\/j.vaccine.2018.08.007","volume":"36","author":"AT Newall","year":"2018","unstructured":"Newall AT, Chen C, Wood JG, Stockwell MS. Within-season influenza vaccine waning suggests potential net benefits to delayed vaccination in older adults in the United States. Vaccine. 2018;36(39):5910\u20135.","journal-title":"Vaccine."},{"key":"1687_CR41","unstructured":"World Health Organisation. Vaccines against influenza WHO position paper, November 2012. 2012 47(87 ):461\u201376."},{"key":"1687_CR42","volume-title":"WHO recommendations on the composition of influenza virus vaccines","author":"World Health Organisation","year":"2019","unstructured":"World Health Organisation. WHO recommendations on the composition of influenza virus vaccines 2019. Available from: https:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/en\/. [updated 2019; cited 2019 July 5]."},{"issue":"5","key":"1687_CR43","first-page":"544","volume":"64","author":"JM Ferdinands","year":"2017","unstructured":"Ferdinands JM, Fry AM, Reynolds S, Petrie J, Flannery B, Jackson ML, et al. Intraseason waning of influenza vaccine protection: evidence from the US influenza vaccine effectiveness network, 2011-12 through 2014-15. Clin Infect Dis. 2017;64(5):544\u201350.","journal-title":"Clin Infect Dis"},{"issue":"43","key":"1687_CR44","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1016\/j.vaccine.2017.09.035","volume":"35","author":"J Puig-Barbera","year":"2017","unstructured":"Puig-Barbera J, Mira-Iglesias A, Tortajada-Girbes M, Lopez-Labrador FX, Librero-Lopez J, Diez-Domingo J, et al. Waning protection of influenza vaccination during four influenza seasons, 2011\/2012 to 2014\/2015. Vaccine. 2017;35(43):5799\u2013807.","journal-title":"Vaccine."},{"issue":"10","key":"1687_CR45","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/cid\/ciy770","volume":"68","author":"GT Ray","year":"2019","unstructured":"Ray GT, Lewis N, Klein NP, Daley MF, Wang SV, Kulldorff M, et al. Intraseason waning of influenza vaccine effectiveness. Clin Infect Dis. 2019;68(10):1623\u201330.","journal-title":"Clin Infect Dis"},{"key":"1687_CR46","volume-title":"CDC Vaccine Price List","author":"Centers for Disease Control and Prevention (CDC)","year":"2019","unstructured":"Centers for Disease Control and Prevention (CDC). CDC Vaccine Price List 2019. Available from: https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/awardees\/vaccine-management\/price-list\/index.html. [updated 1 September 2019; cited 2019 November 11]."},{"issue":"2","key":"1687_CR47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","volume":"93","author":"E Marseille","year":"2015","unstructured":"Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015;93(2):118\u201324.","journal-title":"Bull World Health Organ"},{"issue":"7","key":"1687_CR48","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jval.2017.12.016","volume":"21","author":"AA Leech","year":"2018","unstructured":"Leech AA, Kim DD, Cohen JT, Neumann PJ. Use and misuse of cost-effectiveness analysis thresholds in low- and middle-income countries: trends in cost-per-DALY studies. Value Health. 2018;21(7):759\u201361.","journal-title":"Value Health"},{"key":"1687_CR49","unstructured":"Revill P, Ochalek J, Lomas J, Nakamura R, Woods B, Rollinger A, et al. Cost-effectiveness thresholds: guiding health care spending for population health improvement [version 1; not peer reviewed]. F1000Research. 2017;6(489):1\u201324."},{"key":"1687_CR50","doi-asserted-by":"crossref","first-page":"A109","DOI":"10.1016\/j.vaccine.2014.12.079","volume":"33","author":"C Sigei","year":"2015","unstructured":"Sigei C, Odaga J, Mvundura M, Madrid Y, Clark AD. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda. Vaccine. 2015;33:A109\u2013A18.","journal-title":"Vaccine."},{"issue":"7","key":"1687_CR51","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2471\/BLT.06.034686","volume":"85","author":"AO Akumu","year":"2007","unstructured":"Akumu AO, English M, Scott JA, Griffiths UK. Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya. Bull World Health Organ. 2007;85(7):511\u20138.","journal-title":"Bull World Health Organ"},{"issue":"6","key":"1687_CR52","doi-asserted-by":"crossref","first-page":"e67324","DOI":"10.1371\/journal.pone.0067324","volume":"8","author":"P Ayieko","year":"2013","unstructured":"Ayieko P, Griffiths UK, Ndiritu M, Moisi J, Mugoya IK, Kamau T, et al. Assessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan children. PLoS One. 2013;8(6):e67324.","journal-title":"PLoS One"},{"issue":"5","key":"1687_CR53","doi-asserted-by":"crossref","first-page":"e644","DOI":"10.1016\/S2214-109X(18)30562-X","volume":"7","author":"J Ojal","year":"2019","unstructured":"Ojal J, Griffiths U, Hammitt LL, Adetifa I, Akech D, Tabu C, et al. Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya. Lancet Glob Health. 2019;7(5):e644\u2013e54.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"1687_CR54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.vaccine.2012.10.103","volume":"31","author":"S Ozawa","year":"2012","unstructured":"Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review. Vaccine. 2012;31(1):96\u2013108.","journal-title":"Vaccine."},{"issue":"2","key":"1687_CR55","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.smim.2013.05.004","volume":"25","author":"CA MacLennan","year":"2013","unstructured":"MacLennan CA. Vaccines for low-income countries. Semin Immunol. 2013;25(2):114\u201323.","journal-title":"Semin Immunol"},{"key":"1687_CR56","volume-title":"Ministry of Health","author":"Government of Kenya","year":"2019","unstructured":"Government of Kenya. National and County Health Budget Analysis 2018\/2019. In: Ministry of Health. Nairobi: Government of Kenya; 2019."},{"issue":"2","key":"1687_CR57","doi-asserted-by":"crossref","first-page":"e56882","DOI":"10.1371\/journal.pone.0056882","volume":"8","author":"JA Fuller","year":"2013","unstructured":"Fuller JA, Summers A, Katz MA, Lindblade KA, Njuguna H, Arvelo W, et al. Estimation of the national disease burden of influenza-associated severe acute respiratory illness in Kenya and Guatemala: a novel methodology. PLoS One. 2013;8(2):e56882.","journal-title":"PLoS One"},{"issue":"5","key":"1687_CR58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2471\/BLT.14.000514","volume":"92","author":"N Cox","year":"2014","unstructured":"Cox N. Editorial: influenza seasonality: timing and formulation of vaccines. Bull World Health Organisation. 2014;92(5):309\u201384.","journal-title":"Bull World Health Organisation"},{"issue":"7","key":"1687_CR59","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/cid\/ciy748","volume":"68","author":"KJ Rambhia","year":"2018","unstructured":"Rambhia KJ, Rambhia MT. Early bird gets the flu: what should be done about waning intraseasonal immunity against seasonal influenza? Clin Infect Dis. 2018;68(7):1235\u201340.","journal-title":"Clin Infect Dis"},{"key":"1687_CR60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.coi.2018.04.010","volume":"53","author":"F Zhou","year":"2018","unstructured":"Zhou F, Trieu M-C, Davies R, Cox RJ. Improving influenza vaccines: challenges to effective implementation. Curr Opin Immunol. 2018;53:88\u201395.","journal-title":"Curr Opin Immunol"},{"issue":"8","key":"1687_CR61","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/cid\/cix468","volume":"65","author":"C Arriola","year":"2017","unstructured":"Arriola C, Garg S, Anderson EJ, Ryan PA, George A, Zansky SM, et al. Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza. Clin Infect Dis. 2017;65(8):1289\u201397.","journal-title":"Clin Infect Dis"},{"key":"1687_CR62","doi-asserted-by":"crossref","unstructured":"Tempia S, Moyes J, Cohen AL, Walaza S, Edoka I, McMorrow ML, et al. Health and economic burden of influenza-associated illness in South Africa, 2013\u20132015. Influenza and other respiratory viruses. 2019;13(5):484\u201395.","DOI":"10.1111\/irv.12650"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01687-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-020-01687-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01687-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T23:15:52Z","timestamp":1629414952000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-01687-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1687"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-01687-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"assertion":[{"value":"5 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Permission to undertake secondary data analysis of de-identified SARI surveillance data collected from patients admitted at county referral hospitals, was obtained from the Kenyatta National Hospital \u2013 University of Nairobi Ethics Review Committee (P18\/01\/2017).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"223"}}